Hybrid therapy for ventricular arrhythmia management.
Optimum arrhythmia management has evolved to couple ICD therapy with catheter ablative and drug therapy to attempt to eliminate or reduce arrhythmia risk. No longer should the clinician approach such therapy as a choice among single alternative strategies only. Optimum patient management includes not only recognition of the indications and benefits of such hybrid therapy but also a complete understanding of potential pitfalls of such therapy.
Marchlinski
F E
FE
Electrophysiology Section of the Division of Cardiology, University of Pennsylvania Health System, Philadelphia, USA. marchlin@mail.med.upenn.edu
Zado
E S
ES
Callans
D J
DJ
Patel
V V
VV
Ashar
M S
MS
Hsia
H H
HH
Russo
A M
AM
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D004554:Electric Countershock; D004562:Electrocardiography; D006339:Heart Rate; D006801:Humans; D017180:Tachycardia, Ventricular / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents